Oculis Holding AG
OCS-01
diabetic macular edema (DME)
Countdown
177days
Catalyst readout · ~ Dec 31, 2026 estimated
What's at stake
A key catalyst for OCS-01 (diabetic macular edema (DME)) is expected ~ Dec 31, 2026.
Primary source
· SEC 6-K
verified 12h ago
“if positive, an NDA submission to the FDA is planned for Q4 2026.”